NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Retains The Investor Relations Group of New York

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (Amex & TSX: NBY), a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments, has retained the New York City-based The Investor Relations Group, Inc. (IRG), to serve as its investor relations and corporate communications firm.